The DOI matches its Crossref record; 103 of the 103 references it cites were found in a registry or an index.
xCT: A Critical Molecule That Links Cancer Metabolism to Redox Signaling
Open accessAbstract
and its combination with chemotherapeutic agents or immunotherapy to suppress tumor growth and overcome drug resistance are also discussed.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Ferroptosis: An Iron-Dependent Form of Nonapoptotic Cell Death
Dixon, S. J., Lemberg, K. M., Lamprecht, M. R., Skouta, R., Zaitsev, E. M., Gleason, C. E., Patel, D. N., Bauer, A. J., Cantley, A. M., Yang, W. S., et al. (2012) · Cell · doi:10.1016/j.cell.2012.03.042 · Cited by 18,691
Ferroptosis: A Regulated Cell Death Nexus Linking Metabolism, Redox Biology, and Disease
Stockwell, B. R., Friedmann Angeli, J. P., Bayir, H., Bush, A. I., Conrad, M., Dixon, S. J., Fulda, S., Gascón, S., Hatzios, S. K., Kagan, V. E., et al. (2017) · Cell · doi:10.1016/j.cell.2017.09.021 · Cited by 7,695
Targeting cancer cells by ROS-mediated mechanisms: a radical therapeutic approach?
Trachootham, D., Alexandre, J., & Huang, P. (2009) · Nature Reviews Drug Discovery · doi:10.1038/nrd2803 · Cited by 5,452
Self-citationFerroptosis as a p53-mediated activity during tumour suppression
Jiang, L., Kon, N., Li, T., Wang, S.-J., Su, T., Hibshoosh, H., Baer, R., & Gu, W. (2015) · Nature · doi:10.1038/nature14344 · Cited by 3,398
Discovery and saturation analysis of cancer genes across 21 tumour types
Lawrence, M. S., Stojanov, P., Mermel, C. H., Robinson, J. T., Garraway, L. A., Golub, T. R., Meyerson, M., Gabriel, S. B., Lander, E. S., & Getz, G. (2014) · Nature · doi:10.1038/nature12912 · Cited by 3,096
CD8+ T cells regulate tumour ferroptosis during cancer immunotherapy
Wang, W., Green, M., Choi, J. E., Gijón, M., Kennedy, P. D., Johnson, J. K., Liao, P., Lang, X., Kryczek, I., Sell, A., et al. (2019) · Nature · doi:10.1038/s41586-019-1170-y · Cited by 2,880
The role of iron and reactive oxygen species in cell death
Dixon, S. J., & Stockwell, B. R. (2014) · Nature Chemical Biology · doi:10.1038/nchembio.1416 · Cited by 2,381
Cysteine depletion induces pancreatic tumor ferroptosis in mice
Badgley, M. A., Kremer, D. M., Maurer, H. C., DelGiorno, K. E., Lee, H.-J., Purohit, V., Sagalovskiy, I. R., Ma, A., Kapilian, J., Firl, C. E. M., et al. (2020) · Science · doi:10.1126/science.aaw9872 · Cited by 1,294
Thiol chemistry and specificity in redox signaling
Winterbourn, C. C., & Hampton, M. B. (2008) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2008.05.004 · Cited by 1,226
Frequent Mutations of Chromatin Remodeling Gene ARID1A in Ovarian Clear Cell Carcinoma
Jones, S., Wang, T.-L., Shih, I.-M., Mao, T.-L., Nakayama, K., Roden, R., Glas, R., Slamon, D., Diaz, L. A., Vogelstein, B., et al. (2010) · Science · doi:10.1126/science.1196333 · Cited by 1,219
Ishimoto, T., Nagano, O., Yae, T., Tamada, M., Motohara, T., Oshima, H., Oshima, M., Ikeda, T., Asaba, R., Yagi, H., et al. (2011) · Cancer Cell · doi:10.1016/j.ccr.2011.01.038 · Cited by 1,192
Buettner, R., Mora, L. B., & Jove, R. (2002) · PubMed · Cited by 1,185
Sato, H., Tamba, M., Ishii, T., & Bannai, S. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.17.11455 · Cited by 1,109
Trachootham, D., Zhou, Y., Zhang, H., Demizu, Y., Chen, Z., Pelicano, H., Chiao, P. J., Achanta, G., Arlinghaus, R. B., Liu, J., et al. (2006) · Cancer Cell · doi:10.1016/j.ccr.2006.08.009 · Cited by 1,080
Lang, X., Green, M. D., Wang, W., Yu, J., Choi, J. E., Jiang, L., Liao, P., Zhou, J., Zhang, Q., Dow, A., et al. (2019) · Cancer Discovery · doi:10.1158/2159-8290.cd-19-0338 · Cited by 1,047
BAP1 links metabolic regulation of ferroptosis to tumour suppression
Zhang, Y., Shi, J., Liu, X., Feng, L., Gong, Z., Koppula, P., Sirohi, K., Li, X., Wei, Y., Lee, H., et al. (2018) · Nature Cell Biology · doi:10.1038/s41556-018-0178-0 · Cited by 1,013
Self-citationHarris, I. S., Treloar, A. E., Inoue, S., Sasaki, M., Gorrini, C., Lee, K. C., Yung, K. Y., Brenner, D., Knobbe-Thomsen, C. B., Cox, M. A., et al. (2015) · Cancer Cell · doi:10.1016/j.ccell.2014.11.019 · Cited by 993
The Tumor Suppressor p53 Limits Ferroptosis by Blocking DPP4 Activity
Xie, Y., Zhu, S., Song, X., Sun, X., Fan, Y., Liu, J., Zhong, M., Yuan, H., Zhang, L., Billiar, T. R., et al. (2017) · Cell Reports · doi:10.1016/j.celrep.2017.07.055 · Cited by 952
Self-citationKoppula, P., Zhang, Y., Zhuang, L., & Gan, B. (2018) · Cancer Communications · doi:10.1186/s40880-018-0288-x · Cited by 915
Nrf2-Keap1 pathway promotes cell proliferation and diminishes ferroptosis
Fan, Z., Wirth, A.-K., Chen, D., Wruck, C. J., Rauh, M., Buchfelder, M., & Savaskan, N. (2017) · Oncogenesis · doi:10.1038/oncsis.2017.65 · Cited by 692
Gout, P., Buckley, A., Simms, C., & Bruchovsky, N. (2001) · Leukemia · doi:10.1038/sj.leu.2402238 · Cited by 640
Liu, X., Olszewski, K., Zhang, Y., Lim, E. W., Shi, J., Zhang, X., Zhang, J., Lee, H., Koppula, P., Lei, G., et al. (2020) · Nature Cell Biology · doi:10.1038/s41556-020-0496-x · Cited by 589
Timmerman, L. A., Holton, T., Yuneva, M., Louie, R. J., Padró, M., Daemen, A., Hu, M., Chan, D. A., Ethier, S. P., van ‘t Veer, L. J., et al. (2013) · Cancer Cell · doi:10.1016/j.ccr.2013.08.020 · Cited by 573 · cited 2×
“Glutamine sensitivity analysis identifies xCT as a therapeutic target in triple-negative breast tumor tumor growth Timmerman et al.(42) 2013”
Backgroundp53 Suppresses Metabolic Stress-Induced Ferroptosis in Cancer Cells
Tarangelo, A., Magtanong, L., Bieging-Rolett, K. T., Li, Y., Ye, J., Attardi, L. D., & Dixon, S. J. (2018) · Cell Reports · doi:10.1016/j.celrep.2017.12.077 · Cited by 554
Cramer, S. L., Saha, A., Liu, J., Tadi, S., Tiziani, S., Yan, W., Triplett, K., Lamb, C., Alters, S. E., Rowlinson, S., et al. (2017) · Nature Medicine · doi:10.1038/nm.4232 · Cited by 538
Self-citationThe Deubiquitylase OTUB1 Mediates Ferroptosis via Stabilization of SLC7A11
Liu, T., Jiang, L., Tavana, O., & Gu, W. (2019) · Cancer Research · doi:10.1158/0008-5472.can-18-3037 · Cited by 490
Effector T Cells Abrogate Stroma-Mediated Chemoresistance in Ovarian Cancer
Wang, W., Kryczek, I., Dostál, L., Lin, H., Tan, L., Zhao, L., Lu, F., Wei, S., Maj, T., Peng, D., et al. (2016) · Cell · doi:10.1016/j.cell.2016.04.009 · Cited by 422
Self-citationATF4 promotes angiogenesis and neuronal cell death and confers ferroptosis in a xCT-dependent manner
Chen, D., Fan, Z., Rauh, M., Buchfelder, M., Eyupoglu, I. Y., & Savaskan, N. (2017) · Oncogene · doi:10.1038/onc.2017.146 · Cited by 421
Hu, K., Li, K., Lv, J., Feng, J., Chen, J., Wu, H., Cheng, F., Jiang, W., Wang, J., Pei, H., et al. (2020) · Journal of Clinical Investigation · doi:10.1172/jci124049 · Cited by 404
Sato, M., Kusumi, R., Hamashima, S., Kobayashi, S., Sasaki, S., Komiyama, Y., Izumikawa, T., Conrad, M., Bannai, S., & Sato, H. (2018) · Scientific Reports · doi:10.1038/s41598-018-19213-4 · Cited by 403
Perspective on Oncogenic Processes at the End of the Beginning of Cancer Genomics
Ding, L., Bailey, M. H., Porta-Pardo, E., Thorsson, V., Colaprico, A., Bertrand, D., Gibbs, D. L., Weerasinghe, A., Huang, K.-L., Tokheim, C., et al. (2018) · Cell · doi:10.1016/j.cell.2018.03.033 · Cited by 399
Self-citationThe x cystine/glutamate antiporter: A potential target for therapy of cancer and other diseases
Lo, M., Wang, Y., & Gout, P. W. (2008) · Journal of Cellular Physiology · doi:10.1002/jcp.21366 · Cited by 399
Non-canonical inhibition of DNA damage-dependent ubiquitination by OTUB1
Nakada, S., Tai, I., Panier, S., Al-Hakim, A., Iemura, S.-I., Juang, Y.-C., O’Donnell, L., Kumakubo, A., Munro, M., Sicheri, F., et al. (2010) · Nature · doi:10.1038/nature09297 · Cited by 357
Stromal control of cystine metabolism promotes cancer cell survival in chronic lymphocytic leukaemia
Zhang, W., Trachootham, D., Liu, J., Chen, G., Pelicano, H., Garcia-Prieto, C., Lu, W., Burger, J. A., Croce, C. M., Plunkett, W., et al. (2012) · Nature Cell Biology · doi:10.1038/ncb2432 · Cited by 357
Self-citationxCT (SLC7A11)-mediated metabolic reprogramming promotes non-small cell lung cancer progression
Ji, X., Qian, J., Rahman, S. M. J., Siska, P. J., Zou, Y., Harris, B. K., Hoeksema, M. D., Trenary, I. A., Heidi, C., Eisenberg, R., et al. (2018) · Oncogene · doi:10.1038/s41388-018-0307-z · Cited by 350
Autocrine Glutamate Signaling Promotes Glioma Cell Invasion
Lyons, S. A., Chung, W. J., Weaver, A. K., Ogunrinu, T., & Sontheimer, H. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-2034 · Cited by 342
Cystine-Glutamate Transporter SLC7A11 in Cancer Chemosensitivity and Chemoresistance
Huang, Y., Dai, Z., Barbacioru, C., & Sadée, W. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-4267 · Cited by 340
An Acquired Vulnerability of Drug-Resistant Melanoma with Therapeutic Potential
Wang, L., Leite de Oliveira, R., Huijberts, S., Bosdriesz, E., Pencheva, N., Brunen, D., Bosma, A., Song, J.-Y., Zevenhoven, J., Los-de Vries, G. T., et al. (2018) · Cell · doi:10.1016/j.cell.2018.04.012 · Cited by 327
Inhibiting the system xC−/glutathione axis selectively targets cancers with mutant-p53 accumulation
Liu, D. S., Duong, C. P., Haupt, S., Montgomery, K. G., House, C. M., Azar, W. J., Pearson, H. B., Fisher, O. M., Read, M., Guerra, G. R., et al. (2017) · Nature Communications · doi:10.1038/ncomms14844 · Cited by 321
Inhibition of Cystine Uptake Disrupts the Growth of Primary Brain Tumors
Chung, W. J., Lyons, S. A., Nelson, G. M., Hamza, H., Gladson, C. L., Gillespie, G. Y., & Sontheimer, H. (2005) · The Journal of Neuroscience · doi:10.1523/jneurosci.5258-04.2005 · Cited by 316
Lim, J. K. M., Delaidelli, A., Minaker, S. W., Zhang, H.-F., Colovic, M., Yang, H., Negri, G. L., von Karstedt, S., Lockwood, W. W., Schaffer, P., et al. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1821323116 · Cited by 308
Koppula, P., Zhang, Y., Shi, J., Li, W., & Gan, B. (2017) · Journal of Biological Chemistry · doi:10.1074/jbc.m117.798405 · Cited by 304
A Positive Feedback Loop between Akt and mTORC2 via SIN1 Phosphorylation
Yang, G., Murashige, D. S., Humphrey, S. J., & James, D. E. (2015) · Cell Reports · doi:10.1016/j.celrep.2015.07.016 · Cited by 295
Targeting the Vulnerability of Glutathione Metabolism in ARID1A-Deficient Cancers
Ogiwara, H., Takahashi, K., Sasaki, M., Kuroda, T., Yoshida, H., Watanabe, R., Maruyama, A., Makinoshima, H., Chiwaki, F., Sasaki, H., et al. (2019) · Cancer Cell · doi:10.1016/j.ccell.2018.12.009 · Cited by 289
Franco, R., Panayiotidis, M. I., & Cidlowski, J. A. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m703091200 · Cited by 272
Habib, E., Linher-Melville, K., Lin, H.-X., & Singh, G. (2015) · Redox Biology · doi:10.1016/j.redox.2015.03.003 · Cited by 271
Zhu, T., Shi, L., Yu, C., Dong, Y., Qiu, F., Shen, L., Qian, Q., Zhou, G., & Zhu, X. (2019) · Theranostics · doi:10.7150/thno.32867 · Cited by 264
Reactive oxygen species-mediated therapeutic response and resistance in glioblastoma
Singer, E., Judkins, J., Salomonis, N., Matlaf, L., Soteropoulos, P., McAllister, S., & Soroceanu, L. (2015) · Cell Death & Disease · doi:10.1038/cddis.2014.566 · Cited by 249
Dynamic roles of p53-mediated metabolic activities in ROS-induced stress responses
Jiang, L., Hickman, J. H., Wang, S.-J., & Gu, W. (2015) · Cell Cycle · doi:10.1080/15384101.2015.1068479 · Cited by 231
Lo, M., Ling, V, Wang, Y. Z., & Gout, P. W. (2008) · British Journal of Cancer · doi:10.1038/sj.bjc.6604485 · Cited by 221
Ye, P., Mimura, J., Okada, T., Sato, H., Liu, T., Maruyama, A., Ohyama, C., & Itoh, K. (2014) · Molecular and Cellular Biology · doi:10.1128/mcb.00221-14 · Cited by 208
Gu, Y., Albuquerque, C. P., Braas, D., Zhang, W., Villa, G. R., Bi, J., Ikegami, S., Masui, K., Gini, B., Yang, H., et al. (2017) · Molecular Cell · doi:10.1016/j.molcel.2017.05.030 · Cited by 208
Effective elimination of fludarabine-resistant CLL cells by PEITC through a redox-mediated mechanism
Trachootham, D., Zhang, H., Zhang, W., Feng, L., Du, M., Zhou, Y., Chen, Z., Pelicano, H., Plunkett, W., Wierda, W. G., et al. (2008) · Blood · doi:10.1182/blood-2008-04-149815 · Cited by 203
Self-citationMolecular Cloning and Expression of Human xCT, the Light Chain of Amino Acid Transport System x c ¯
Sato, H., Tamba, M., Kuriyama-Matsumura, K., Okuno, S., & Bannai, S. (2000) · Antioxidants & Redox Signaling · doi:10.1089/ars.2000.2.4-665 · Cited by 200
Daher, B., Parks, S. K., Durivault, J., Cormerais, Y., Baidarjad, H., Tambutte, E., Pouysségur, J., & Vučetić, M. (2019) · Cancer Research · doi:10.1158/0008-5472.can-18-3855 · Cited by 200
Liu, X.-X., Li, X.-J., Zhang, B., Liang, Y.-J., Zhou, C.-X., Cao, D.-X., He, M., Chen, G.-Q., He, J.-R., & Zhao, Q. (2011) · FEBS Letters · doi:10.1016/j.febslet.2011.04.018 · Cited by 194
Okuno, S., Sato, H., Kuriyama-Matsumura, K., Tamba, M., Wang, H., Sohda, S., Hamada, H., Yoshikawa, H., Kondo, T., & Bannai, S. (2003) · British Journal of Cancer · doi:10.1038/sj.bjc.6600786 · Cited by 191
Yoshikawa, M., Tsuchihashi, K., Ishimoto, T., Yae, T., Motohara, T., Sugihara, E., Onishi, N., Masuko, T., Yoshizawa, K., Kawashiri, S., et al. (2013) · Cancer Research · doi:10.1158/0008-5472.can-12-3609-t · Cited by 191
Xc− inhibitor sulfasalazine sensitizes colorectal cancer to cisplatin by a GSH-dependent mechanism
Ma, M.-Z., Chen, G., Wang, P., Lu, W.-H., Zhu, C.-F., Song, M., Yang, J., Wen, S., Xu, R.-H., Hu, Y., et al. (2015) · Cancer Letters · doi:10.1016/j.canlet.2015.07.031 · Cited by 186
Self-citationSleire, L., Skeie, B. S., Netland, I. A., Førde, H. E., Dodoo, E., Selheim, F., Leiss, L., Heggdal, J. I., Pedersen, P.-H., Wang, J., et al. (2015) · Oncogene · doi:10.1038/onc.2015.60 · Cited by 175
Carew, J. S., Zhou, Y., Albitar, M., Carew, J. D., Keating, M. J., & Huang, P. (2003) · Leukemia · doi:10.1038/sj.leu.2403043 · Cited by 174
Self-citationArensman, M. D., Yang, X. S., Leahy, D. M., Toral-Barza, L., Mileski, M., Rosfjord, E. C., Wang, F., Deng, S., Myers, J. S., Abraham, R. T., et al. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1814932116 · Cited by 171
Deubiquitinases Maintain Protein Homeostasis and Survival of Cancer Cells upon Glutathione Depletion
Harris, I. S., Endress, J. E., Coloff, J. L., Selfors, L. M., McBrayer, S. K., Rosenbluth, J. M., Takahashi, N., Dhakal, S., Koduri, V., Oser, M. G., et al. (2019) · Cell Metabolism · doi:10.1016/j.cmet.2019.01.020 · Cited by 170
Disruption of xCT inhibits cancer cell metastasis via the caveolin-1/β-catenin pathway
Chen, R.-S., Song, Y.-M., Zhou, Z.-Y., Tong, T., Li, Y., Fu, M., Guo, X.-L., Dong, L.-J., He, X., Qiao, H.-X., et al. (2009) · Oncogene · doi:10.1038/onc.2008.414 · Cited by 164
Goji, T., Takahara, K., Negishi, M., & Katoh, H. (2017) · Journal of Biological Chemistry · doi:10.1074/jbc.m117.814392 · Cited by 154
Polewski, M. D., Reveron‐Thornton, R. F., Cherryholmes, G. A., Marinov, G. K., Cassady, K. M., & Aboody, K. S. (2016) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-16-0028 · Cited by 151
Guan, J., Lo, M., Dockery, P., Mahon, S., Karp, C. M., Buckley, A. R., Lam, S., Gout, P. W., & Wang, Y.-Z. (2009) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-008-0894-4 · Cited by 134
Disruption of xCT inhibits cell growth via the ROS/autophagy pathway in hepatocellular carcinoma
Guo, W., Zhao, Y., Zhang, Z., Tan, N., Zhao, F., Ge, C., Liang, L., Jia, D., Chen, T., Yao, M., et al. (2011) · Cancer Letters · doi:10.1016/j.canlet.2011.07.024 · Cited by 134
Antioxidant enzyme activities and the production of MDA and 8-oxo-dG in chronic lymphocytic lerkenia
Oltra, A. M., Carbonell, F., Tormos, C., Iradi, A., & Sáez, G. T. (2001) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(01)00521-4 · Cited by 127
Sulfasalazine‐induced cystine starvation: Potential use for prostate cancer therapy
Doxsee, D. W., Gout, P. W., Kurita, T., Lo, M., Buckley, A. R., Wang, Y., Xue, H., Karp, C. M., Cutz, J., Cunha, G. R., et al. (2006) · The Prostate · doi:10.1002/pros.20508 · Cited by 124
Increased xCT Expression Correlates With Tumor Invasion and Outcome in Patients With Glioblastomas
Takeuchi, S., Wada, K., Toyooka, T., Shinomiya, N., Shimazaki, H., Nakanishi, K., Nagatani, K., Otani, N., Osada, H., Uozumi, Y., et al. (2012) · Neurosurgery · doi:10.1227/neu.0b013e318276b2de · Cited by 116
Tsuchihashi, K., Okazaki, S., Ohmura, M., Ishikawa, M., Sampetrean, O., Onishi, N., Wakimoto, H., Yoshikawa, M., Seishima, R., Iwasaki, Y., et al. (2016) · Cancer Research · doi:10.1158/0008-5472.can-15-2121 · Cited by 115
Lien, E. C., Ghisolfi, L., Geck, R. C., Asara, J. M., & Toker, A. (2017) · Science Signaling · doi:10.1126/scisignal.aao6604 · Cited by 106
Sulfasalazine inhibits the growth of primary brain tumors independent of nuclear factor‐κB
Chung, W. J., & Sontheimer, H. W. (2009) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2009.06129.x · Cited by 84
Wada, F., Koga, H., Akiba, J., Niizeki, T., Iwamoto, H., Ikezono, Y., Nakamura, T., Abe, M., Masuda, A., Sakaue, T., et al. (2018) · Cancer Science · doi:10.1111/cas.13728 · Cited by 81
Narang, V. S., Pauletti, G. M., Gout, P. W., Buckley, D. J., & Buckley, A. R. (2007) · Chemotherapy · doi:10.1159/000100812 · Cited by 78
Qiang, W., Cahill, J. M., Liu, J., Kuang, X., Liu, N., Scofield, V. L., Voorhees, J. R., Reid, A. J., Yan, M., Lynn, W. S., et al. (2004) · Journal of Virology · doi:10.1128/jvi.78.21.11926-11938.2004 · Cited by 78
Self-citationZhang, L., Huang, Y., Ling, J., Zhuo, W., Yu, Z., Luo, Y., & Zhu, Y. (2018) · Future Oncology · doi:10.2217/fon-2017-0540 · Cited by 76
xCT (SLC7A11) expression confers intrinsic resistance to physical plasma treatment in tumor cells
Bekeschus, S., Eisenmann, S., Sagwal, S. K., Bodnar, Y., Moritz, J., Poschkamp, B., Stoffels, I., Emmert, S., Madesh, M., Weltmann, K., et al. (2020) · Redox Biology · doi:10.1016/j.redox.2019.101423 · Cited by 72
Song, Y., Jang, J.-W., Shin, T., Bae, S. M., Kim, J., Kim, K. M., Myung, S., Choi, E. K., & Seo, H. R. (2017) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-017-0511-7 · Cited by 71
Yang, Y., & Yee, D. (2014) · Cancer Research · doi:10.1158/0008-5472.can-13-1803 · Cited by 68
Kinoshita, H., OKABE, H., Beppu, T., Chikamoto, A., Hayashi, H., Imai, K., Mima, K., Nakagawa, S., Ishimoto, T., Miyake, K., et al. (2012) · Oncology Reports · doi:10.3892/or.2012.2162 · Cited by 68
Expression of xCT as a predictor of disease recurrence in patients with colorectal cancer.
Sugano, K., Maeda, K., Ohtani, H., Nagahara, H., Shibutani, M., & Hirakawa, K. (2015) · PubMed · Cited by 65
xCT deficiency accelerates chemically induced tumorigenesis
Nabeyama, A., Kurita, A., Asano, K., Miyake, Y., Yasuda, T., Miura, I., Nishitai, G., Arakawa, S., Shimizu, S., Wakana, S., et al. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0912827107 · Cited by 65
Nandar, W., Neely, E. B., Unger, E., & Connor, J. R. (2013) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2013.02.009 · Cited by 64
Seib, T., Patel, S. A., & Bridges, R. J. (2011) · Glia · doi:10.1002/glia.21176 · Cited by 64
Miyoshi, S., Tsugawa, H., Matsuzaki, J., Hirata, K., Mori, H., Saya, H., Kanai∥, T., & Suzuki, H. (2018) · Anticancer Research · doi:10.21873/anticanres.12969 · Cited by 64
Shitara, K., Doi, T., Nagano, O., Fukutani, M., Hasegawa, H., Nomura, S., Sato, A., Kuwata, T., Asai, K., Einaga, Y., et al. (2017) · Gastric Cancer · doi:10.1007/s10120-017-0720-y · Cited by 63
Participation of xCT in melanoma cell proliferation in vitro and tumorigenesis in vivo
Shin, S., Jeong, B., Wall, B., Li, J., Shan, N. L., Wen, Y., Goydos, J. S., & Chen, S. (2018) · Oncogenesis · doi:10.1038/s41389-018-0098-7 · Cited by 63
Cystine requirement of continuous human lymphoid cell lines of normal and leukemic origin
Iglehart, J. K., York, R. M., Modest, A. P., Lazarus, H., & Livingston, D. M. (1977) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)66953-x · Cited by 62
Wang, S., Wung, C.-H., Chen, M.-S., Chen, C., Yin, P., Yeh, T.-S., Chang, Y.-L., Chou, Y., Hung, H.-H., & Lee, H. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19113389 · Cited by 62
Dai, L., Cao, Y., Chen, Y., Parsons, C. H., & Qin, Z. (2014) · Journal of Hematology & Oncology · doi:10.1186/1756-8722-7-30 · Cited by 61
Otsubo, K., Nosaki, K., Imamura, C. K., Ogata, H., Fujita, A., Sakata, S., Hirai, F., Toyokawa, G., Iwama, E., Harada, T., et al. (2017) · Cancer Science · doi:10.1111/cas.13309 · Cited by 61
Ogihara, K., Kikuchi, E., Okazaki, S., Hagiwara, M., Takeda, T., Matsumoto, K., Kosaka, T., Mikami, S., Saya, H., & Oya, M. (2019) · Cancer Science · doi:10.1111/cas.13960 · Cited by 60
Linher‐Melville, K., Haftchenary, S., Gunning, P. T., & Singh, G. (2015) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-015-2412-4 · Cited by 57
Increased cystine uptake capability associated with malignant progression of Nb2 lymphoma cells
Gout, P., Kang, Y. J., Buckley, D., Bruchovsky, N., & Buckley, A. (1997) · Leukemia · doi:10.1038/sj.leu.2400739 · Cited by 53
Liu, R., Blower, P. E., Pham, A., Fang, J., Dai, Z., Wise, C., Green, B., Teitel, C. H., Ning, B., Ling, W., et al. (2007) · Molecular Pharmacology · doi:10.1124/mol.107.039644 · Cited by 46
Lee, J. R., Roh, J., Lee, S. M., Park, Y., Cho, K., Choi, S., Nam, S. Y., & Kim, S. Y. (2018) · Head & Neck · doi:10.1002/hed.25331 · Cited by 40
Kobayashi, S., Kuwata, K., Sugimoto, T., Igarashi, K., Osaki, M., Okada, F., Fujii, J., Bannai, S., & Sato, H. (2012) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2012.09.040 · Cited by 36
Horibe, S., Kawauchi, S., Tanahashi, T., Sasaki, N., Mizuno, S., & Rikitake, Y. (2018) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2018.11.055 · Cited by 33
Administering xCT Inhibitors Based on Circadian Clock Improves Antitumor Effects
Okazaki, F., Matsunaga, N., Hamamura, K., Suzuki, K., Nakao, T., Okazaki, H., Kutsukake, M., Fukumori, S., Tsuji, Y., & To, H. (2017) · Cancer Research · doi:10.1158/0008-5472.can-17-0720 · Cited by 30
xCT expression modulates cisplatin resistance in Tca8113 tongue carcinoma cells
Zhang, P., Wang, W., WEI, Z., Li, X., YANG, X., & Du, Y. (2016) · Oncology Letters · doi:10.3892/ol.2016.4571 · Cited by 29
Clemons, N. J., Liu, D. S., Duong, C. P., & Phillips, W. A. (2017) · Molecular & Cellular Oncology · doi:10.1080/23723556.2017.1344757 · Cited by 18
Cited by
Disulfidptosis: disulfide stress–induced cell death
Liu, X., Zhuang, L., & Gan, B. (2024) · Trends in Cell Biology · doi:10.1016/j.tcb.2023.07.009 · Cited by 299
Ferroptosis in the tumor microenvironment: perspectives for immunotherapy
Xu, H., Ye, D., Ren, M., Zhang, H., & Bi, F. (2021) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2021.06.014 · Cited by 294
Oxidative Stress in the Tumor Microenvironment and Its Relevance to Cancer Immunotherapy
Aboelella, N. S., Brandle, C., Kim, T., Ding, Z.-C., & Zhou, G. (2021) · Cancers · doi:10.3390/cancers13050986 · Cited by 286
Molecular basis for redox control by the human cystine/glutamate antiporter system xc−
Parker, J. L., Deme, J. C., Kolokouris, D., Kuteyi, G., Biggin, P. C., Lea, S. M., & Newstead, S. (2021) · Nature Communications · doi:10.1038/s41467-021-27414-1 · Cited by 272
The Role of Cystine/Glutamate Antiporter SLC7A11/xCT in the Pathophysiology of Cancer
Jyotsana, N., Ta, K. T., & DelGiorno, K. E. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.858462 · Cited by 272
Metadata
- Authors
- Liu, J., Xia, X., & Huang, P.
- Venue
- Molecular Therapy
- Publisher
- Elsevier BV
- Published
- 2020-11
- Volume
- 28
- Issue
- 11
- Pages
- 2358-2366
- ISSN
- 1525-0016 (ISSN-L)
- OpenAlex
- W3082064887
- Cited by
- 347
- References
- 103
- FWCI
- 9.35
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.